News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...
Groundbreaking single-dose vaccine found effective in preventing HIV - Strategy may lead to new vaccines that only need to be ...
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...
According to a phase 1 trial, the experimental HIVconsvX vaccine is safe and immunogenic among sub-Saharan African ...
The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
News-Medical.Net on MSN2d
New dual-adjuvant vaccine strategy offers hope in the fight against HIVIn the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback